Polymer microparticles for drug delivery

• US 5,869,103 A
• Filed: 04/04/1997
• Issued: 02/09/1999
• Est. Priority Date: 06/18/1994
• Status: Expired due to Fees

• Current Assignee: West Pharmaceutical Services Drug Delivery & Clinical Research Centre Ltd
• Original Assignee: Danbiosyst UK Ltd
• Inventors: Jenkins, Paul George, Yeh, Ming-Kung, Coombes, Alan Gerald, Davis, Stanley Stewart
• Primary Examiner(s): Azpuru, Carlos A.
• Application Number:
  US08/750,738
• Time in Patent Office: 676 Days
• Field of Search: 424/501, 424/502, 264/4.1, 264/4.6
• US Class Current: 424/501
• CPC Class Codes: A61K 9/1641 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
• CPC Class Codes: A61K 9/1647 Polyesters, e.g. poly(lactide-co-glycolide)

Abstract

Provided are biodegradable microparticles, which exhibit a linear release profile of active agent, and methods for making the microparticles. The microparticles include a mixture of a biodegradable polymer, a water soluble polymer, and an active agent. Preferred biodegradable polymers include lactide homopolymers or copolymers of lactide and glycolide, and preferred water soluble polymers include poly(ethylene glycol) (PEG) or PEG copolymers. The microparticles are made using an emulsion/solvent extraction method, in which the continuous phase of the secondary emulsion contains an organic solvent that is miscible with the organic solvent in the primary emulsion.

Claims

1. A microparticle comprising a mixture of:

(a) a biodegradable polymer,

(b) a water soluble polymer which has a molecular weight of about 8000 Daltons or higher, and

(c) an active agent;

characterised in that the microparticle exhibits an active agent release profile which is substantially linear with time.

3. The microparticle of claim 1 wherein the water soluble polymer is a block copolymer comprising PEG as one of the blocks.

4. The microparticle of claim 1 wherein the microparticle has a size in the range of between about 10 nm and 200 μ

m.

5. The microparticle of claim 1 wherein the biodegradable polymer is a lactide homopolymer or a copolymer of lactide and glycolide.

6. The microparticle of claim 5 wherein the biodegradable polymer is poly(lactide co-glycolide) with a molecular weight in the range of between about 5 and 100 kD.

7. The microparticle of claim 1 wherein the active agent is a peptide, polypeptide or a protein.

8. The microparticle of claim 1 wherein the active agent is selected from the group consisting of DNA, vaccines, allergens and antigens.

9. The microparticle of claim 8 wherein the active agent is selected from the group consisting of insulin, luteinizing hormone releasing hormones, growth hormones, interferons colony stimulating factors, and somatostatin.

10. The microparticle of claim 1 wherein the ratio of the biodegradable polymer to the water soluble polymer is in the range of between about 99.9:

1.0 and 10;

90.

11. The microparticle of claim 1 which is suitable for administration by intramuscular, intravenous, subcutaneous, intraarticular or intraperitoneal injection.

12. The microparticle of claim 1 which is suitable for administration to the dermal or epidermal layer of the skin by injection or needleless injector system.

13. The microparticle of claim 1 which is suitable for administration to the eye, nose, oral cavity, gastrointestinal tract or vaginal cavity.

14. The microparticle of claim 1 which is suitable for administration to plants.

2. A microparticle comprising a mixture of:

(a) a biodegradable polymer,

(b) a water soluble polymer, and

(c) an active agent;

wherein the water soluble polymer is a block copolymer comprising PEG as one of the blocks.

15. A method of forming polymer microparticles containing an active agent comprising the steps of:

a. forming an aqueous solution, water-in-oil (W/O) emulsion or a suspension of the active agent in a first organic solvent;

b. mixing the aqueous solution, W/O emulsion or suspension of the active agent with a polymer solution formed in a second organic solvent; and

c. mixing the emulsion so formed in step b. with a continuous phase comprising a third organic solvent which is miscible with the first and second organic solvents and is not a solvent for the polymer.

16. The method of claim 15 wherein the solvent used to produce the water-in-oil emulsion or the suspension of the active agent contains the dissolved polymer and step b. is omitted.

17. The method of claim 15 wherein the polymer solution comprises a mixture of a biodegradable polymer and a water soluble polymer.

18. The method of claim 15 wherein the third organic solvent is a lower alcohol between one and six carbon atoms.

19. The method of claim 18 wherein the third organic solvent is methanol.

20. The method of claim 15 wherein the first and second organic solvent are the same or different and are selected from dichloromethane (DCM), chloroform, acetone, ethyl acetate, ethyl formate and miscible mixtures thereof.

21. The method of claim 15 wherein the first organic solvent contains a stabiliser.

22. The method of claim 15 wherein the continuous phase contains a surfactant.

24. A microparticle obtained by the method of claim 15.

25. The microparticle of claim 24 wherein the microparticle exhibits an active agent release profile which is substantially linear with time.

26. The microparticle of claim 24 wherein the water soluble polymer is a block copolymer comprising PEG as one of the blocks.

23. A method of administering an active agent to an animal or human comprising administering a microparticle comprising a mixture of

(a) a biodegradable polymer,

(b) a water soluble polymer, and

(c) the active agent,

wherein the microparticle exhibits an active agent release profile which is substantially linear with time.